ALLR
Price
$1.00
Change
-$0.00 (-0.00%)
Updated
Jul 18, 04:57 PM (EDT)
Capitalization
15.08M
NRXP
Price
$2.91
Change
-$0.10 (-3.32%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
59.1M
Interact to see
Advertisement

ALLR vs NRXP

Header iconALLR vs NRXP Comparison
Open Charts ALLR vs NRXPBanner chart's image
Allarity Therapeutics
Price$1.00
Change-$0.00 (-0.00%)
Volume$200
Capitalization15.08M
NRX Pharmaceuticals
Price$2.91
Change-$0.10 (-3.32%)
Volume$950
Capitalization59.1M
ALLR vs NRXP Comparison Chart in %
Loading...
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLR vs. NRXP commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLR is a Hold and NRXP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (ALLR: $1.00 vs. NRXP: $3.03)
Brand notoriety: ALLR and NRXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLR: 62% vs. NRXP: 43%
Market capitalization -- ALLR: $15.08M vs. NRXP: $59.1M
ALLR [@Biotechnology] is valued at $15.08M. NRXP’s [@Biotechnology] market capitalization is $59.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLR’s FA Score shows that 1 FA rating(s) are green whileNRXP’s FA Score has 0 green FA rating(s).

  • ALLR’s FA Score: 1 green, 4 red.
  • NRXP’s FA Score: 0 green, 5 red.
According to our system of comparison, ALLR is a better buy in the long-term than NRXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLR’s TA Score shows that 5 TA indicator(s) are bullish while NRXP’s TA Score has 4 bullish TA indicator(s).

  • ALLR’s TA Score: 5 bullish, 4 bearish.
  • NRXP’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ALLR and NRXP are a good buy in the short-term.

Price Growth

ALLR (@Biotechnology) experienced а -7.41% price change this week, while NRXP (@Biotechnology) price change was -7.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ALLR is expected to report earnings on May 09, 2025.

NRXP is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXP($59.1M) has a higher market cap than ALLR($15.1M). NRXP has higher P/E ratio than ALLR: NRXP (0.36) vs ALLR (0.00). NRXP YTD gains are higher at: 37.727 vs. ALLR (-14.530). ALLR (-23.16M) and NRXP (-24.11M) have comparable annual earnings (EBITDA) . ALLR has more cash in the bank: 25.2M vs. NRXP (5.55M). ALLR has less debt than NRXP: ALLR (1.36M) vs NRXP (8.4M). ALLR (0) and NRXP (0) have equivalent revenues.
ALLRNRXPALLR / NRXP
Capitalization15.1M59.1M26%
EBITDA-23.16M-24.11M96%
Gain YTD-14.53037.727-39%
P/E Ratio0.000.360%
Revenue00-
Total Cash25.2M5.55M454%
Total Debt1.36M8.4M16%
FUNDAMENTALS RATINGS
NRXP: Fundamental Ratings
NRXP
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLRNRXP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 23 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MZTFF34.68N/A
N/A
Mizrahi Tefahot Bank Ltd.
AILLP62.75N/A
N/A
Ameren Illinois Company
SMTEF6.38N/A
N/A
Smart Eye
OUTKY2.03N/A
N/A
Outokumpu OYJ
PAYD2.70N/A
N/A
Paid, Inc.

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with RNAC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+0.66%
RNAC - NRXP
86%
Closely correlated
-5.58%
NCNA - NRXP
85%
Closely correlated
-6.77%
TAOX - NRXP
84%
Closely correlated
+0.97%
AGEN - NRXP
83%
Closely correlated
+5.66%
ALLR - NRXP
81%
Closely correlated
N/A
More